1. Home
  2. PEN vs XPEV Comparison

PEN vs XPEV Comparison

Compare PEN & XPEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEN
  • XPEV
  • Stock Information
  • Founded
  • PEN 2004
  • XPEV 2015
  • Country
  • PEN United States
  • XPEV China
  • Employees
  • PEN N/A
  • XPEV N/A
  • Industry
  • PEN Medical/Dental Instruments
  • XPEV Auto Manufacturing
  • Sector
  • PEN Health Care
  • XPEV Consumer Discretionary
  • Exchange
  • PEN Nasdaq
  • XPEV Nasdaq
  • Market Cap
  • PEN 11.1B
  • XPEV 12.0B
  • IPO Year
  • PEN 2015
  • XPEV 2020
  • Fundamental
  • Price
  • PEN $267.51
  • XPEV $19.71
  • Analyst Decision
  • PEN Strong Buy
  • XPEV Buy
  • Analyst Count
  • PEN 16
  • XPEV 8
  • Target Price
  • PEN $291.60
  • XPEV $21.71
  • AVG Volume (30 Days)
  • PEN 413.7K
  • XPEV 14.8M
  • Earning Date
  • PEN 05-06-2025
  • XPEV 03-18-2025
  • Dividend Yield
  • PEN N/A
  • XPEV N/A
  • EPS Growth
  • PEN N/A
  • XPEV N/A
  • EPS
  • PEN 0.36
  • XPEV N/A
  • Revenue
  • PEN $1,194,615,000.00
  • XPEV $5,598,814,778.00
  • Revenue This Year
  • PEN $14.26
  • XPEV $80.67
  • Revenue Next Year
  • PEN $14.29
  • XPEV $33.93
  • P/E Ratio
  • PEN $733.61
  • XPEV N/A
  • Revenue Growth
  • PEN 12.86
  • XPEV 33.22
  • 52 Week Low
  • PEN $148.00
  • XPEV $6.55
  • 52 Week High
  • PEN $310.00
  • XPEV $27.16
  • Technical
  • Relative Strength Index (RSI)
  • PEN 44.19
  • XPEV 44.03
  • Support Level
  • PEN $273.00
  • XPEV $20.35
  • Resistance Level
  • PEN $288.57
  • XPEV $24.20
  • Average True Range (ATR)
  • PEN 8.21
  • XPEV 1.07
  • MACD
  • PEN -0.93
  • XPEV -0.71
  • Stochastic Oscillator
  • PEN 38.19
  • XPEV 3.62

About PEN Penumbra Inc.

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.

About XPEV XPeng Inc.

Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 141,000 EVs in 2023, accounting for about 2% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.

Share on Social Networks: